What this means
This study has not started signing up people yet and has no results. It will ask how common immune conditions are during menopause and how they relate to symptoms and health.
Plain-English summary written by an AI model from the registry listing.
- Status
- Opening soon
- Who can join
- Ages 40–60
- Where
- 1 site
The science
- Registered title
- Inflammation, Autoimmunity and Healthy Ageing in Menopause Transition. An Observational, Cross-sectional Study
- Trial ID
- NCT07784400 ↗
- Phase
- Not applicable
- Study type
- observational
- Conditions
- Autoimmune Diseases, Menopause
- Sponsor
- Fondazione IRCCS Policlinico San Matteo di Pavia
- Ages
- 40 Years to 60 Years
- Dates
- First posted Aug 25, 2026 · updated Aug 25, 2026
Registry summary
The goal of this observational study is to investigate the prevalence of autoimmune or immune-mediated conditions in women during the menopausal transition (aged 40-60 years). The main questions it aims to answer are:
- What is the prevalence of autoimmune or immune-mediated conditions in women aged 40-60 years across different reproductive stages?
- How do inflammatory markers, resilience, lifestyle factors, and allostatic load scores relate to menopause-related symptoms and general health?
Participants will complete evaluations, provide samples for clinical, immunological, and biochemical markers, and undergo assessments to analyze symptom burden and psychosocial determinants during the menopausal transition.
Sites (1)
- Fondazione IRCCS Policlinico San Matteo di Pavia, Pavia, Lombardy, Italy